« Previous
Next »
Journal of Hepatology
Volume 50, Issue 3
, Pages
584-591
, March 2009
Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: An open label trial
To access this article, please choose from the options below
☆ The abstract of this work was presented at the Annual Conference of the American College of Gastroenterology (ACG), November, 2007. The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the drug involved either in the past or present and they did not receive funding from the manufacturers to carry out their research.
PII: S0168-8278(08)00792-7
doi: 10.1016/j.jhep.2008.10.024
© 2009 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 50, Issue 3
, Pages
584-591
, March 2009
